To overcome multidrug resistance in cancer treatment, many strategies have been adopted, including chemotherapy with a combination of anti-tumor drugs and a P-gp (p-glycoprotein) inhibitor, inactivation of the MDR-associated gene by the targeting of specific mRNA, and development of a nanocarrier drug delivery system [6,7]. The gene discussed is PGP; the disease is cancer.